Abstract

Detection of microvascular obstruction (MO) with gadolinium first-pass perfusion (FP) and late gadolinium enhancement (LGE) MRI predicts outcomes of STEMI patients. Previous data indicate the presence of MO early after MI correlates to worse prognosis and left ventricular (LV) remodeling. Nonetheless, FP and early hypoenhancement on LGE may persist after reperfused STEMI for a variable period of time.

Highlights

  • Detection of microvascular obstruction (MO) with gadolinium first-pass perfusion (FP) and late gadolinium enhancement (LGE) MRI predicts outcomes of STEMI patients

  • We investigate whether the persistence of MO by CMR was related to worse left ventricular (LV) remodeling at 6 month after STEMI

  • LV ejection fraction at six month was significantly lower in persistent MO group compared to transient and absent MO (43.6±9.7% vs 47.1±7.9% vs 62.5 ±15.7%, p=0.006 by ANOVA, p

Read more

Summary

Introduction

Detection of microvascular obstruction (MO) with gadolinium first-pass perfusion (FP) and late gadolinium enhancement (LGE) MRI predicts outcomes of STEMI patients. Previous data indicate the presence of MO early after MI correlates to worse prognosis and left ventricular (LV) remodeling. FP and early hypoenhancement on LGE may persist after reperfused STEMI for a variable period of time. Purpose We investigate whether the persistence of MO by CMR was related to worse LV remodeling at 6 month after STEMI

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.